Tirzepatide

Short Description:


Stock Sample is Free & Available

  • FOB Price: US $0.5 - 9,999 / Piece
  • Min.Order Quantity: 100 Piece/Pieces
  • Supply Ability: 10000 Piece/Pieces per Month
  • Product Detail

    Application

    Product Tags

    Tirzepatide is a new type of GIP/GLP-1 receptor double agonist withpotent glucose control and weight loss effects. It was approved by the USFDA in May 2022 as an adjoint therapy with diet and exercise to improveblood glucose control in adults with type 2 diabetes.

    Product Characteristics

    Item

    Specification

    Result

    Appearance

    White or almost white powder

    White powder

    Molecular Ion Mass

    4813.45

    Conforms

    Purity (HPLC)

    ≥99.0%

    Conforms

    Peptide Content (HPLC)

    ≥90.0%

    Conforms

    Sodium Ion (C)

    ≤ 5.0%

    Conforms

    Water Content (K.F)

    ≤ 8.0%

    Conforms

    pH

    7.0~9.0 (C=5mg/ml)

    Conforms

    Solubility

    Report Value

    50mg/ml (H₂O)

    Endotoxin

    ≤ 10 EU/mg

    Conforms

    Microbial Limits

    TAMC≤50 cfu/0.1g; TYMC≤50 cfu/0.1g

    Conforms

    Storage

    /

    Store in a sealed container, protect from light, and store at -20±5°C.

    Product Advantages

    • Production Form: Fully synthetic, significant weight loss, good GLP-1 agonist activity, and GIP receptor agonist activity.
    • Production Advantages: Double agonist, high purity, high yield, and affordable price.

    Our product is intended for research use only and is not for individual consumer use.

    For more information and product catalogs, please email: info@uniwellbio.com or call: +86 28 88808601 or leave a message online. We are happy to serve you.

     




  • Previous:
  • Next:

  • Health Care Product, Dietary Supplements, Cosmetics

    health products

    RELATED PRODUCTS